| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Molecular Medicine [C. L., M. N.], Department of Medicine, Division of Hematology [M. Ho., C. Z., M. B., D. X.], Microbiology and Tumor Biology Center [M. He.], Karolinska Hospital and Institutet, SE-171 76 Stockholm, Sweden; Molecular Biology Laboratory, Medical Research Laboratories, Taisho Pharmaceutical Co., Ltd., Yoshino-Cho, Omiyanshi, Saitama, 330-8530 Japan [T. K.]; Shaanxi Provincial Hospital, Xian, 710068 Peoples Republic of China [C. Z.]; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island 02912 [J. M. S.]; Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan 49503 [B. T. T.]
Reconstitution of telomerase activity by ectopic expression of telomerase reverse transcriptase (hTERT) results in an immortal phenotype in various types of normal human cells, including fibroblasts. Despite lack of transformation characteristics, it is unclear whether hTERT-immortalized cells are physiologically and biochemically the same as their normal counterparts. Here, we compared the gene expression profiles of normal and hTERT-immortalized fibroblasts by using a cDNA microarray containing 20,736 cDNA clones and identified 172 dysregulated genes or expressed sequence tags (ESTs). One of the highly expressed genes in the hTERT-immortalized fibroblasts (hTERT-BJ cells) encodes epiregulin, a potent growth factor. Blockade of epiregulin reduced the growth of hTERT-BJ cells and colony formation of hTERT-transformed fibroblasts. Moreover, inhibition of epiregulin function in immortal hTERT-BJ cells triggered a senescence program. Our results suggest that both activation of telomerase and subsequent induction of epiregulin are required for sustained cell proliferation. Given the significant difference in gene expression profiles between normal and hTERT-immortalized fibroblasts and the close relationship between epiregulin and tumorigenesis, we conclude that hTERT-immortalized cells may not replace their normal counterparts for studies of normal cell biology and that the use of hTERT for expansion of normal human cells for therapeutic purposes must be approached with caution.
This article has been cited by other articles:
![]() |
E. J. Chapman, G. Kelly, and M. A. Knowles Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells Mol. Cancer Res., July 1, 2008; 6(7): 1154 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, Z. Ge, C. Liu, Z. Liu, M. Bjorkholm, J. Jia, and D. Xu CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells Clin. Cancer Res., June 15, 2008; 14(12): 3722 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas PNAS, March 4, 2008; 105(9): 3539 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Menzel, M. Migliaccio, D. R. Goldstein, S. Dahoun, M. Delorenzi, and N. Rufer Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase J. Immunol., September 15, 2006; 177(6): 3657 - 3668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhou, X.-m. Li, and R. M. Lavker Transcriptional Profiling of Enriched Populations of Stem Cells Versus Transient Amplifying Cells: A COMPARISON OF LIMBAL AND CORNEAL EPITHELIAL BASAL CELLS J. Biol. Chem., July 14, 2006; 281(28): 19600 - 19609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. J. Schreurs, M. A. J. A. Hermsen, R. I. K. Geltink, K. B. J. Scholten, A. A. T. P. Brink, E. W. M. Kueter, M. Tijssen, C. J. L. M. Meijer, B. Ylstra, G. A. Meijer, et al. Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes Blood, October 15, 2005; 106(8): 2663 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Burns, B. M. Abdallah, P. Guldberg, J. Rygaard, H. D. Schroder, and M. Kassem Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells Cancer Res., April 15, 2005; 65(8): 3126 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lee, R. S. Pearsall, S. Das, S. K. Dey, V. L. Godfrey, and D. W. Threadgill Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage Mol. Cell. Biol., October 15, 2004; 24(20): 8907 - 8916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Benanti and D. A. Galloway Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence Mol. Cell. Biol., April 1, 2004; 24(7): 2842 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, I. Shats, N. Erez, X. Tang, S. Senderovich, A. Meerson, Y. Tabach, N. Goldfinger, D. Ginsberg, C. C. Harris, et al. Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype Cancer Res., November 1, 2003; 63(21): 7147 - 7157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |